Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Safety Study of Eltrombopag Combined With Azacitidine to Treat Myelodysplastic Syndrome (MDS) [Phase 1]
A Phase 1 safety study evaluating the combination of eltrombopag with azacitidine in myelodysplastic syndrome has been completed.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Phase 1, Phase 2]
This completed Phase 1/2 trial from UCSF evaluated a conditioning regimen of busulfan, antithymocyte globulin, and fludarabine followed by d…
-
EMA withdrawal · 2012-07-27EMA Withdrawn: Refludan (lepirudin) — Celgene Europe Ltd.
EMA withdrew Refludan (lepirudin) from the market in 2012, with thromboembolism and thrombocytopenia as therapeutic areas.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [Phase 2]
This Phase 2 trial compared the oral thrombopoietin receptor agonist SB497115 to placebo in adults with thrombocytopenia due to chronic hepa…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Platelet Count Trends in Pre-eclamptic Parturients
A completed Northwestern University study investigated platelet count trends in preeclamptic parturients, with results posted on 2012-02-17.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Phase 3]
Open-label Phase 3 trial of romiplostim in adults with immune thrombocytopenia (ITP) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-07-21Clinical Trial Update: Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease [Phase 2]
Phase 2 clinical trial assessing eltrombopag for improving thrombocytopenia in MYH9-related disease; results have been posted after completi…
-
CLINICAL_TRIALS trial_result · 2011-07-12Clinical Trial Update: Study of the Effect of Differing Platelet Transfusion Times in Neonates [NA]
This completed clinical trial evaluated whether differing platelet transfusion times affect outcomes in neonates with thrombocytopenia. Resu…
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents [Phase 2]
Phase 2 trial assessing the safe and effective dose of romiplostim in patients with myelodysplastic syndrome receiving hypomethylating agent…
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Transfusing Neonates Based on Platelet Mass
A completed clinical trial evaluating platelet-mass guided transfusion in neonates with thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid [Phase 2]
Phase 2 safety and efficacy study of romiplostim (AMG 531) in patients with myelodysplastic syndromes receiving Revlimid. Results were poste…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial update reporting the determination of a safe dose of romiplostim (AMG 531) in patients with myelodysplastic syndromes, with re…
-
CLINICAL_TRIALS trial_result · 2010-11-08Clinical Trial Update: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures [Phase 3]
Phase 3 trial investigating eltrombopag to reduce platelet transfusions in patients with chronic liver disease and thrombocytopenia undergoi…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: Aspirin in Patients With Myocardial Infarction and Thrombocytopenia [Phase 3]
A Phase 3 trial evaluating aspirin in patients with myocardial infarction and thrombocytopenia was terminated, and results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-09-23Clinical Trial Update: Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease [Phase 2]
Phase 2 pharmacokinetics study of eltrombopag in Japanese patients with thrombocytopenia due to chronic liver disease; the study has complet…
-
CLINICAL_TRIALS trial_result · 2010-05-12Clinical Trial Update: Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Amgen sponsored a retrospective and prospective observational study of patients with idiopathic thrombocytopenic purpura (ITP); the trial st…
-
CLINICAL_TRIALS research · 2010-04-21Clinical Trial Update: Identifying Characteristics of Bone Marrow Failure Syndromes
This clinical trial update describes a study to identify characteristics of bone marrow failure syndromes and related hematologic conditions…
-
CLINICAL_TRIALS trial_result · 2010-04-14Clinical Trial Update: Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days [Phase 3]
Phase 3 trial evaluating the efficacy and safety of pathogen-inactivated platelets stored for up to seven days in patients with thrombocytop…
-
CLINICAL_TRIALS research · 2010-03-29Clinical Trial Update: Study of Incidence, of Mechanisms and Prognosis of the Thrombopenia From Patients of Reanimation.
A completed clinical trial update examining the incidence, mechanisms, and prognosis of thrombocytopenia in patients requiring reanimation.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products [EARLY_Phase 1]
An early Phase 1 trial assessing the safety and performance of MIRASOL PRT treated platelet transfusion products. The study concerns patient…
-
CLINICAL_TRIALS trial_result · 2009-07-16Clinical Trial Update: Optimal Platelet Dose Strategy for Management of Thrombocytopenia [Phase 3]
Phase 3 clinical trial evaluating the optimal platelet dose strategy for managing thrombocytopenia. Results were posted in July 2009.
-
CLINICAL_TRIALS trial_result · 2008-06-13Clinical Trial Update: Mechanism of Thrombocytopenia in Infants
A completed clinical trial investigating the mechanism of thrombocytopenia in infants, including associations with small for gestational age…
-
CLINICAL_TRIALS trial_result · 2008-05-28Clinical Trial Update: Strategies for Transfusion of Platelets (SToP) [Phase 3]
The SToP Phase 3 trial evaluating platelet transfusion strategies for thrombocytopenia has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Identification of Donors of CD36-Deficient Platelets Among Japanese Individuals on the NIH Campus
This completed NIH Clinical Center study identified Japanese individuals on the NIH campus who have CD36-deficient platelets and examined th…
-
CLINICAL_TRIALS trial_result · 2008-01-18Clinical Trial Update: Thrombopoietin Levels and Platelet Transfusion in Neonates
A completed clinical trial assessing thrombopoietin levels and platelet transfusion in neonates with thrombocytopenia.